February 2009

Influenza vaccine – hold the eggs

Influenza virus undergoes continuous antigenic variation, necessitating production of a new vaccine each year. This is not a trivial task. Six to nine months before the flu season begins, the viral strains for inclusion in the vaccine must be selected. High-yielding recombinant strains are produced and grown in embryonated chicken eggs. This year, approximately 140 …

Influenza vaccine – hold the eggs Read More »

Cosavirus – a new human picornavirus

The WHO strategy to eradicate poliomyelitis depends upon immunization of every child under 5 years of age, and nationwide AFP (acute flaccid paralysis) surveillance to identify cases of poliomyelitis. A laboratory network then determines whether AFP is caused by poliovirus. Recently a new member of the picornavirus family was identified in children with non-poliovirus AFP. …

Cosavirus – a new human picornavirus Read More »

Ebola virus glycoprotein antagonizes tetherin

The innate response to virus infection is a marvel: when confronted with an invading microbe, it responds rapidly by producing interferons and other cytokines which establish an antiviral state. Its effectiveness is underscored by the fact that every viral genome must encode countermeasures that modulate its activity. A recent paper in PNAS adds another mechanism …

Ebola virus glycoprotein antagonizes tetherin Read More »

Scroll to Top